CoreCap Advisors’s Arcosa ACA Stock Holding History

CoreCap Advisors’s Portfolio ACA Stock Details ACA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-133	Closed	-$7K	–	561
2021 Q4	$7K	Buy	+133	New	+$7.11K	﹤0.01%	1642

Other funds holding ACA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CoreCap Advisors's ACA Position: Q1 2022 in Review

CoreCap Advisors sold out of Arcosa (ACA) in Q1 2022, closing a stake of 133 shares — an estimated $7K sold.

CoreCap Advisors first reported a position in ACA in Q4 2021 and held it in 1 quarter. The position peaked at $7K in Q4 2021. 255 funds tracked by Wall St. Rank hold ACA as of Q1 2022.

CoreCap Advisors reported no remaining Arcosa position as of Q1 2022 after selling out during the quarter.
CoreCap Advisors sold 133 Arcosa shares in Q1 2022, an estimated $7K.
CoreCap Advisors first reported a position in Arcosa in Q4 2021 and held it in 1 quarter.
CoreCap Advisors's Arcosa position peaked at $7K in Q4 2021.
255 funds tracked by Wall St. Rank held Arcosa as of Q1 2022.

Based on CoreCap Advisors's 13F filing for Q1 2022, filed 29 Apr 2022.